Israel has always been at the leading edge of the COVID-19 pandemic, both in the spread of infections, the vaccination phases, the use of antiviral drugs, and thanks to the creation of Enovid NONS viral protector spray. A new spike of coronavirus there could teach the rest of the world that what’s been happening in Israel could be coming their way soon.
No other country has been so much the focus of attention during the short history of the COVID-19 pandemic as Israel. As a trailblazer both in the spread of infections, and how science and governments have been able to contain the spread, Israel set an example. Recent developments in Israel are precursors to what could happen in the rest of the world by the end of 2022.
Why is the world so interested in Israel’s experience with coronavirus?
Several unique features came from Israel’s geographic location, high population density, advanced social medicine infrastructure and population patterns. These made it both a high target for the virus throughout the pandemic, and also an ideal real-life laboratory in which preventative and treatment methods could be developed, tried and rolled out without massive cost.Â- Israel has a relatively small population, which lives in high-density in the center of the country. Israel has a population density of nearly 500 per square kilometer, with 93% living in urban areas. For comparison, the population density in the United States is 36 per square kilometer, and 82% of the population is urban. The population density in Western Europe is 181 per square kilometer, and 79% is urban
- Israel has one of the most advanced socialized medicine systems, where all citizens belong to state-backed health funds and are entitled to a basket of consultations, treatments and medications at a very low cost
- Israel is a country advanced in medical research and innovation, with top-ranking universities and pharmaceutical research institutions at the cutting-edge of science.